CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Lung ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04823234
NCT04823234N/ACompleted

Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women - "The PINK-CO Protocol"

Azienda Sanitaria-Universitaria Integrata di Udine·observational·Posted Mar 30, 2021·Updated Sep 28, 2021

In Brief

An observational study evaluating Lung ultrasound for Pregnancy Complications and Covid19. Completed, enrolled 40 participants across 1 site.

Detailed Summary

SARS-CoV-2 impact on pregnant women is not well known yet. Some authors demonstrated that lung ultrasound can give similar results if compared to chest computed tomography and better results if compared to chest x-rays without radiations and limited risks for mother and fetus. The Lung Ultrasound Score (LUS) can be used to asses the entity and monitor the evolution of lung impairment. Some authors described an artifact, the "light beam", as a typical ultrasound sign in COVID-19 positive patients. With our study we hypothesize to understand the prevalence of this sign and other ultrasound signs in pregnant COVID-19 positive patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 30, 2021
Enrollment StartMar 10, 2021
Primary CompletionJun 30, 2021
Study CompletionSep 15, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.3 years ago

Interventions

Lung ultrasoundother

Lung ultrasound signs in Covid 19 positive pregnant patients